Skip to Main Content

Good morning, everyone, and welcome to another working week. And this should be an exciting one, yes? After all, there is an election taking place and who knows what may happen. All the more reason to start quaffing cups of stimulation to prepare for whatever lies ahead. On that note, we also offer you some tidbits. Hope you have a productive day and please keep us in mind when something intriguing occurs. We accept secret documents, you know …

The battle over Prop 61 — the California ballot measure aimed at lowering drug prices — looks to be tightening, Reuters reports. The measure would require state agencies to pay the same as the Department of Veterans Affairs. A survey of nearly 1,500 registered voters at the end of October found 47 percent of voters would vote yes and 47 percent would vote no. The pharmaceutical industry donated $109 million to fight the effort.


New data-driven pricing plans drug makers are trying to replace the “pay-per-pill” approach are increasingly used for cancer treatments but will take longer for other conditions, such as multiple sclerosis, Jens Grueger, who heads global pricing and market access at Roche, tells Reuters. “At this point in time, we don’t see a way that it would practically work. The data are not available, but it would be very much in line with our pricing philosophy.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Hi Mike,

    I understand your concerns. However, it’s worth noting that the FDA doesn’t issue fines. In the event of an enforcement matter, regarding any operator – a brand-name drug maker or a compounding pharmacy, for instance – the FDA does work with the US Department of Justice, but any penalties are paid to the treasury.


  • What is the problem at the FDA? We have known for years that the Chinese have been selling adulterated products to the USA, but yet NOTHING is being done to stop the gross business practices. Does the FDA think sending a BS letter “warning them that they have to allow inspections and must stop exporting tainted drugs to the US (otc’s and rx’s) or we might do something” is ridiculous !!!!
    It appears that the FDA is only concerned with grabbing the quick buck, as they sue the rest of the industry. Isn’t it funny how quick they will attack a pharmacy here and put them thru the grinder but turna blind eye to other countries that are selling outright to our country. What do they do with all the money they are receiving in these fines ? It is very apparent that money is the gateway to our justice system. 30 million here, 120 million there, trade the lives of our children for tobacco money. It is documented to cause several types of cancer, yet they continue to allow it’s production ? I’ve rambled enough, to many pockets are being filled to stop the cancer growing in Washington. Maybe, just maybe incoming president Trump will put a stop to it. And just how did Hillary get away with those millions of dollars from the pharmaceutical PAC’s? I guess that’s her and Bill’s retirement. It is time for change!

Comments are closed.